For tirzepatide at the highest dose, the SURMOUNT-1 trial showed an average of 22.5% weight loss at 72 weeks, which represents one of the most significant weight loss results ever achieved with any medication
First-line therapies, including metformin, sodium-glucose cotransporter-2 inhibitors (SGLT-2i), and Glucagon-like peptide-1 (GLP-1) receptor agonists, are selected according to patient-specific risk factors
This article explains how GLP-1 coverage actually works, when sleep apnea can change eligibility, and how treatment decisions are approached in a medically appropriate way
Bodybuilders: Melanotan 2 can help bodybuilders achieve and maintain a natural, deep tan without spending excessive time in the sun or using tanning products
Chiecho and colleagues showed that acetyl-L-carnitine in rats altered the DNA in the spinal cord cells by increasing the production of mGlu2 receptors, an important receptor for pain relief [3]
Y.VykhovanetsO